CNKHIGH SIGNALFINANCIAL10-K

Cinemark shows mixed financial performance with substantially improved operating losses but declining net income, while debt increased significantly to $2.5B and stockholders' equity fell sharply.

The substantial improvement in operating losses suggests better operational efficiency, but the decline in net income indicates significant non-operating headwinds, likely related to the 40% debt increase. The sharp reduction in stockholders' equity combined with higher debt levels creates a more leveraged capital structure that warrants close monitoring.

Comparing 2026-02-18 vs 2025-02-19View on EDGAR →
FINANCIAL ANALYSIS

Cinemark's financial picture presents contrasting trends with operating performance improving meaningfully while bottom-line results deteriorated substantially. The company increased its debt burden by over 40% to $2.5B while stockholders' equity declined by 59% to $323M, creating a significantly more leveraged balance sheet. The combination of reduced equity cushion and higher debt load, despite operational improvements, signals a fundamental shift in the company's financial risk profile.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+66.6%
-$755.0M-$252.5M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Stockholders Equity
Balance Sheet
-59%
$788.0M$322.9M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Net Income
P&L
-55.4%
$309.7M$138.2M

Net income declined 55.4% — review whether driven by operations, interest costs, or non-recurring items.

Total Debt
Balance Sheet
+40.3%
$1.8B$2.5B

Debt increased 40.3% — substantial leverage increase; assess whether deployed for growth or covering losses.

Current Liabilities
Balance Sheet
+26.8%
$606.4M$769.1M

Current liabilities rose 26.8% — increased short-term obligations, watch current ratio.

Inventory
Balance Sheet
+22.7%
$12.6M$15.5M

Inventory built 22.7% — monitor whether demand supports this build or if write-downs may follow.

LANGUAGE CHANGES
NEW — 2026-02-18
PRIOR — 2025-02-19
ADDED
3900 Dallas Parkway Plano , Texas 75093 ( 972 ) 665-1000 Delaware 20-5490327 33-47040 Cinemark USA, Inc.
As of February 13, 2026, 115,526,237 shares of common stock of Cinemark Holdings, Inc.
As of February 13, 2026 , 1,500 shares of Class A common stock, $0.01 par value per share, and 182,648 shares of Class B common stock, no par value per share, of Cinemark USA, Inc.
Business We are a leader and one of the most geographically diverse operators in the theatrical exhibition industry.
As of December 31, 2025, we operated 496 theaters and 5,637 screens in the United States, or U.S.
circuit operated 303 theaters and 4,241 screens and our Latin America circuit operated 193 theaters and 1,396 screens across 13 countries.
We believe our portfolio of high-quality theaters with multiple platforms and amenities provides a preferred destination for moviegoers.
Theatrical Exhibition Industry Overview The success of the theatrical exhibition industry is contingent upon several key factors, including the volume of new film and other content available, the box office performance of new film content released, the duration of the exclusive theatrical release window, and evolving consumer behavior with competition from other forms of in-and-out-of home entertainment.
Domestic Preliminary estimates indicate that North American industry box office revenues were approximately $8.9 billion for 2025.
Films leading the box office during the year ended December 31, 2025 included A Minecraft Movie, Lilo Stitch, Superman, Jurassic World: Rebirth, Zootopia 2, Wicked: For Good, Sinners, The Fantastic Four: First Steps, How to Train Your Dragon, and Avatar: Fire and Ash , among other films.
REMOVED
3900 Dallas Parkway Plano , Texas 75093 (972) 665-1000 Delaware 20-5490327 33-47040 Cinemark USA, Inc.
As of February 12, 2025 , 122,303,972 shares of common stock of Cinemark Holdings, Inc.
As of February 12, 2025 , 1,500 shares of Class A common stock, $0.01 par value per share, and 182,648 shares of Class B common stock, no par value per share, of Cinemark USA, Inc.
Business We are a leader and one of the most geographically diverse operators in the motion picture exhibition industry.
As of December 31, 2024, we operated 497 theaters and 5,653 screens in the United States, or U.S.
circuit operated 304 theaters and 4,255 screens and our Latin America circuit operated 193 theaters and 1,398 screens across 13 countries.
We believe our portfolio of high-quality theaters with multiple platforms and amenities provides a preferred destination for moviegoers and has contributed to our consistent industry-leading results.
Motion Picture Exhibition Industry Overview The success of the theatrical exhibition industry is contingent upon several key factors, including the volume of new film content available, which has been impacted by the effects of the COVID-19 pandemic and more recently the 2023 writers and actors guild strikes (the Hollywood strikes ), as well as the box office performance of new film content released, the duration of the exclusive theatrical release window, and evolving consumer behavior with competition from other forms of in-and-out-of home entertainment.
Domestic Preliminary estimates indicate that North American box office revenues were approximately $8.8 billion for 2024, down approximately 3% compared with 2023 and significantly exceeding industry expectations, demonstrating sustained consumer demand for the theatrical experience.
Films released during the year ended December 31, 2024 included Inside Out 2, Deadpool Wolverine, Wicked, Moana 2, Despicable Me 4, Beetlejuice Beetlejuice, Dune: Part Two, Twisters, Godzilla x Kong: The New Empire, and Kung Fu Panda 4 , among other films.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →